107 related articles for article (PubMed ID: 12812364)
21. Synthesis of cysteinylphenol, cysteaminylphenol, and related compounds, and in vivo evaluation of antimelanoma effect.
Miura S; Ueda T; Jimbow K; Ito S; Fujita K
Arch Dermatol Res; 1987; 279(4):219-25. PubMed ID: 3674957
[TBL] [Abstract][Full Text] [Related]
22. Selective cytotoxicity of a phenolic melanin precursor, 4-S-cysteaminylphenol, on in vitro melanoma cells.
Yamada K; Jimbow K; Engelhardt R; Ito S
Biochem Pharmacol; 1989 Jul; 38(13):2217-21. PubMed ID: 2735958
[No Abstract] [Full Text] [Related]
23. Triphenylmethylamides (TPMAs): Structure-activity relationship of compounds that induce apoptosis in melanoma cells.
Palchaudhuri R; Hergenrother PJ
Bioorg Med Chem Lett; 2008 Nov; 18(22):5888-91. PubMed ID: 18710803
[TBL] [Abstract][Full Text] [Related]
24. The killing effect of 4-S-cysteaminylphenol, a newly synthesised melanin precursor, on B16 melanoma cell lines.
Yamada I; Seki S; Ito S; Suzuki S; Matsubara O; Kasuga T
Br J Cancer; 1991 Feb; 63(2):187-90. PubMed ID: 1997095
[TBL] [Abstract][Full Text] [Related]
25. Comparison of in vivo anti-melanoma effect of enantiomeric alpha-methyl- and alpha-ethyl-4-S-cysteaminylphenol.
Yukitake J; Otake H; Inoue S; Wakamatsu K; Ito S
Melanoma Res; 2004 Apr; 14(2):115-20. PubMed ID: 15057040
[TBL] [Abstract][Full Text] [Related]
26. Tyrosinase mutants are capable of prodrug activation in transfected nonmelanotic cells.
Simonova M; Wall A; Weissleder R; Bogdanov A
Cancer Res; 2000 Dec; 60(23):6656-62. PubMed ID: 11118049
[TBL] [Abstract][Full Text] [Related]
27. Dihydro-1,4-benzothiazine-6,7-dione, the ultimate toxic metabolite of 4-S-cysteaminylphenol and 4-S-cysteaminylcatechol.
Hasegawa K; Ito S; Inoue S; Wakamatsu K; Ozeki H; Ishiguro I
Biochem Pharmacol; 1997 May; 53(10):1435-44. PubMed ID: 9260870
[TBL] [Abstract][Full Text] [Related]
28. Comparison of antimelanoma effects of 4-S-cysteaminylphenol and its homologues.
Inoue S; Hasegawa K; Wakamatsu K; Ito S
Melanoma Res; 1998 Apr; 8(2):105-12. PubMed ID: 9610862
[TBL] [Abstract][Full Text] [Related]
29. Development of an in vitro primary screen for skin depigmentation and antimelanoma agents.
Dooley TP; Gadwood RC; Kilgore K; Thomasco LM
Skin Pharmacol; 1994; 7(4):188-200. PubMed ID: 8024800
[TBL] [Abstract][Full Text] [Related]
30. N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
Yamazaki Y; Kawano Y; Yamanaka A; Maruyama S
Bioorg Med Chem Lett; 2009 Aug; 19(15):4178-82. PubMed ID: 19524439
[TBL] [Abstract][Full Text] [Related]
31. 4-S-cysteaminylphenol and its analogues as substrates for tyrosinase and monoamine oxidase.
Pankovich JM; Jimbow K; Ito S
Pigment Cell Res; 1990 Sep; 3(3):146-9. PubMed ID: 2127097
[TBL] [Abstract][Full Text] [Related]
32. Melanocytotoxicity and antimelanoma effects of phenolic amine compounds in mice in vivo.
Alena F; Jimbow K; Ito S
Cancer Res; 1990 Jun; 50(12):3743-7. PubMed ID: 2340520
[TBL] [Abstract][Full Text] [Related]
33. Exploitation of pigment biosynthesis pathway as a selective chemotherapeutic approach for malignant melanoma.
Jimbow K; Iwashina T; Alena F; Yamada K; Pankovich J; Umemura T
J Invest Dermatol; 1993 Feb; 100(2 Suppl):231S-238S. PubMed ID: 8433013
[TBL] [Abstract][Full Text] [Related]
34. Phenolic melanin precursors provide a rational approach to the design of antitumor agents for melanoma.
Jimbow K; Miura T; Ito S; Ishikawa K
Pigment Cell Res; 1989; 2(1):34-9. PubMed ID: 2717528
[TBL] [Abstract][Full Text] [Related]
35. Selective in vivo and in vitro incorporation and accumulation of phenolic thioether amine into malignant melanoma and identification of a (58 kD) binding glycoprotein.
Yamada K; Jimbow K
Melanoma Res; 1992 Nov; 2(4):225-33. PubMed ID: 1490110
[TBL] [Abstract][Full Text] [Related]
36. N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma.
Jimbow K
Arch Dermatol; 1991 Oct; 127(10):1528-34. PubMed ID: 1929460
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes.
Ito S; Kato T; Ishikawa K; Kasuga T; Jimbow K
Biochem Pharmacol; 1987 Jun; 36(12):2007-11. PubMed ID: 3109434
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of growth inhibition of melanoma cells by 4-S-cysteaminylphenol and its analogues.
Inoue S; Ito S; Wakamatsu K; Jimbow K; Fujita K
Biochem Pharmacol; 1990 Mar; 39(6):1077-83. PubMed ID: 2108682
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and cytotoxic properties of new N-substituted 4-aminophenol derivatives with a potential as antimelanoma agents.
Mascagna D; Ghanem G; Morandini R; d'Ischia M; Misuraca G; Lejeune F; Prota G
Melanoma Res; 1992 May; 2(1):25-32. PubMed ID: 1643421
[TBL] [Abstract][Full Text] [Related]
40. Selective cytotoxicity of N-acetyl-4-S-cysteaminylphenol on follicular melanocytes of black mice.
Wong M; Jimbow K
Br J Dermatol; 1991 Jan; 124(1):56-61. PubMed ID: 1993146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
